Abnormal, enlarged veins in the oesophagus
Aetiology
Portal Hypertension (Primary Cause)
Cause | Mechanism |
Liver cirrhosis (most common) | Increased intrahepatic resistance |
Portal vein thrombosis | Prehepatic obstruction |
Budd–Chiari syndrome | Posthepatic obstruction |
Schistosomiasis | Presinusoidal portal hypertension |
Other (Less Common)
- Non-cirrhotic portal fibrosis
- Congenital hepatic fibrosis
Pathophysiology
- Chronic liver disease → increased portal venous pressure
- Formation of portosystemic collateral circulation
- Dilatation of submucosal veins in distal esophagus
- Thin-walled vessels exposed to trauma and pressure
- Rupture → acute upper GI bleeding
Clinically significant portal hypertension:
Hepatic venous pressure gradient (HVPG) ≥10 mmHgBleeding risk increases when HVPG ≥12 mmHg.
Clinical presentation
Asymptomatic
- Most patients until bleeding occurs
Acute Variceal Bleeding (Medical Emergency)
- Hematemesis
- Melena
- Hematochezia (massive bleed)
- Hypovolemic shock
Associated Signs of Chronic Liver Disease
- Jaundice
- Ascites
- Splenomegaly
- Spider angiomas
- Hepatic encephalopathy
Classification
By Size (Endoscopic)
Grade | Description |
Small | Minimally elevated veins |
Medium | Tortuous veins occupying <⅓ lumen |
Large | Occupying >⅓ of lumen |
High-Risk Stigmata (Endoscopic)
- Red wale markings
- Cherry red spots
- Hematocystic spots


Investigations
- Endoscopy
Management
Hemodynamic Stabilization
- Crystalloid resuscitation
- Restrictive transfusion strategy
- Transfuse if Hb <7 g/dL → Target Hb 7–8 g/dL
- Avoid over-transfusion (↑ portal pressure)
Primary Prophylaxis
Indications
- Medium/large varices
- Small varices with red wale signs
- Decompensated cirrhosis
Options
- Non-selective beta blockers (NSBBs)
NSBBs reduce portal pressure by ↓ cardiac output and splanchnic vasoconstriction.
🚫 Do NOT start NSBBs during active bleeding or shock.
Drug | Starting Dose | Titration | Target | Notes |
Propranolol | 20 mg twice daily | Increase every 2–3 days | HR 55–60 bpm | Combine with EVL |
Nadolol | 20–40 mg once daily | Titrate as above | HR 55–60 bpm | Longer half-life |
Carvedilol | 6.25 mg once daily | Up to 12.5 mg/day | Tolerability | More BP lowering |
- Endoscopic variceal ligation (EVL)
Acute Variceal Bleeding (Rupture)
- Resuscitation - maintain pulse and blood pressure, antibiotics
Drug | Dose | Route | Duration | Indication |
Ceftriaxone | 1 g 1x1 | IV | 5–7 days | First-line (advanced cirrhosis, high resistance) |
Norfloxacin | 400 mg 2x1 | PO | 5–7 days | Alternative if low resistance & stable |
Ciprofloxacin | 400 mg 2x1 | IV | 5–7 days | If ceftriaxone contraindicated |
- Vasoactive Agents
Drug | Loading Dose | Maintenance Dose | Duration | Key Notes |
Terlipressin | 2 mg IV bolus | 1 mg IV every 4–6 h | 2–5 days | ↓ portal pressure; improves survival |
Octreotide | 50 µg IV bolus | 50 µg/h IV infusion | 2–5 days | Widely available; fewer ischemic effects |
Somatostatin | 250 µg IV bolus | 250 µg/h IV infusion | 2–5 days | Alternative to octreotide |
- Endoscopic variceal ligation (EVL)
- Rescue / Bridge Therapy (If Uncontrolled Bleeding)
Therapy | Dose / Use | Duration | Notes |
Balloon tamponade | As per device protocol | ≤24 h | Temporary bridge to TIPS |
TIPS | — | Definitive | For refractory bleeding or early TIPS candidates |
Secondary prophylaxis
- EVL
- β- blockers